HealthTechMovers.com has identified several healthtech stocks which are expected to go “Ex-Dividend” very soon. Remember, if you purchase a stock on its ex-dividend date or after, you will not receive the next dividend payment. Instead, the seller gets the dividend. If you purchase before the ex-dividend date, you get the dividend.
MiningAndMetalMovers.com is also looking into these tickers AVY, CMC, MERC, LIN and more.
If you sell your stock before the ex-dividend date, you also are selling away your right to the stock dividend.
So please keep this in mind.
Below is our latest Dividend Report:
Gilead Sciences
Symbol: GILD
Recent GILD Price: $88.54
Average Analyst Price Target: $84.61 (-4.44%)
GILD Market Cap: $110.34B
Expected Ex-Dividend Date for GILD stock: Dec 14 2022
Expected Payment Date for GILD stock: Dec 29 2022
Expected Dividend & Yield for GILD stock: 3.24%
Recent Analyst Action: Elmar Kraus, analyst at DZ BANK AG, reiterates coverage on Gilead Sciences (GILD) stock in the Healthcare sector with a Hold rating and a price target of $ 90 (3 days ago).
Click for full story on GILD stock >>--------------------------------------------------------------------------
Merck & Company
Symbol: MRK
Recent MRK Price: $108.97
Average Analyst Price Target: $110.27 (1.19%)
MRK Market Cap: $275.80B
Expected Ex-Dividend Date for MRK stock: Dec 14 2022
Expected Payment Date for MRK stock: Jan 09 2023
Expected Dividend & Yield for MRK stock: 2.54%
Recent Analyst Action: Geoff Meacham, analyst at Bank of America Securities, reiterates coverage on Merck & Company (MRK) stock in the Healthcare sector with a Hold rating and a price target of $ 110 (23 hours ago).
Click for full story on MRK stock >>--------------------------------------------------------------------------
Thermo Fisher
Symbol: TMO
Recent TMO Price: $567.6
Average Analyst Price Target: $618.43 (8.96%)
TMO Market Cap: $219.72B
Expected Ex-Dividend Date for TMO stock: Dec 14 2022
Expected Payment Date for TMO stock: Jan 16 2023
Expected Dividend & Yield for TMO stock: 0.20%
Recent Analyst Action: Conor McNamara, analyst at RBC Capital, reiterates coverage on Thermo Fisher (TMO) stock in the Healthcare sector with a Buy rating and a price target of $ 661 (6 days ago).
Click for full story on TMO stock >>--------------------------------------------------------------------------
MiningAndMetalMovers.com keeps investors informed of the top moving stocks within the mining and metal sector. We provide investors with timely information regarding top moving stocks in the health tech sector sourced from our proprietary stocks screens, partner stock analysts and breaking news that identify and monitor stocks that are on the move. Join thousands of investors who already signed up for our free subscription to MiningAndMetalMovers.com.
